EU Grants

GRANT NAME	CODE	TOPIC
FLUVACC	LSHB-CT-2005-518281	Live attenuated replication-defective influenza vaccine
NM4TB	LSHP-CT-2005-018923	New Medicines For Tuberculosis
INTACT	LSHC-CT-2003-506803	Identification of novel targets for cancer therapy
INCA	LSHC-CT-2005-018704	The role of chronic infections in the development of cancer
DIALOK	LSHB-CT-2007-036644	Development of Innovative Assays and Locally acting therapies aiming at critical Kinases in hepatic and renal fibrosis
TBDRUG	LSHP-CT-2006-037217	A SME-STREP for Tuberculosis Drug Development
GROWTHSTOP	LSHC-CT-2006-037731	Identification, development and validation of novel therapeutics targeting programmed cell death in tumors
DIVINOCELL	HEALTH_2007-B	Exploiting Gram-negative cell division targets in the test tube to obtain microbial compounds
NOPERSIST	FP7-SME-2008-1	Novel strategies for the prevention and control of persistent infections
LUNGTARGET	HEALTH.2010.2.4.1-6	New approaches for the targeted therapy of Non-Small Cell Lung Cancer
MM4TB	HEALTH.2010.2.3.2-1	More Medicines for Tuberculosis
ANTIFLU	HEALTH.2010.2.3.3-4	Innovative anti-influenza drugs excluding viral escape
PRIMES	HEALTH.2011.2.1.1-2	Protein interaction machines in oncogenic EGF receptor signalling
OPTATIO	HEALTH.2011.2.4.1-2	Optimizing Targets and Therapeutics In high risk and refractory Multiple Myeloma
TARKINAID	HEALTH.2011.1.4-5	Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases
NEOVASCULOSTOP	HORIZON-EIC-2021-PATHFINDEROPEN-01-01	Natural Intraocular Photoactivation Of Compounds To Fight Retinopathies